Format

Send to

Choose Destination
Hum Antibodies. 2005;14(3-4):59-67.

Antibody polyspecificity and neutralization of HIV-1: a hypothesis.

Author information

1
Duke Human Vaccine Institute, Duke University School of Medicine, Durham NC 27710, USA. hayne002@mc.duke.edu

Abstract

HIV-1 has evolved many ways to evade protective host immune responses, thus creating a number of problems for HIV vaccine developers. In particular, durable, broadly specific neutralizing antibodies to HIV-1 have proved difficult to induce with current HIV-1 vaccine candidates. The recent observation that some broadly neutralizing anti-HIV-1 envelope monoclonal antibodies have polyspecific reactivities to host antigens have raised the hypothesis that one reason antibodies against some of the conserved HIV-1 envelope trimer neutralizing epitopes are not routinely made may be down-regulation of some specificities of anti-HIV-1 antibody producing B cells by host B cell tolerance mechanisms.

PMID:
16720975
PMCID:
PMC2673565
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for IOS Press Icon for PubMed Central
Loading ...
Support Center